In addition, Labelle and colleagues published that platelet-derived TGFβ and direct platelet-tumour cell contacts synergistically activate the TGFβ/Smad and NFκB pathways in cancer cells, resulting in their transition to an invasive mesenchymal-like phenotype and enhanced metastasis in vivo53. Here, TGFB1 is linked to cancer.